Deep vein thrombosis (DVT) and stress gastric ulcers can be serious complications in patients admitted to the intensive care unit. This review discusses the risk factors associated with the development of DVT and stress-related mucosal disease (SRMD), evaluates the available literature on current options for DVT and stress ulcer prophylaxis, and examines the associated adverse effects and optimal duration of therapy.
CrowtherMACookDJGriffithLE. Deep venous thrombosis: Clinically silent in the intensive care unit. J Crit Care. 2005;20:334–340.
4.
IbrahimEHIreguiMPrenticeD. Deep vein thrombosis during prolonged mechanical ventilation despite prophylaxis. Crit Care Med. 2002;30:771–774.
5.
CookDCrowtherMMeadeM. Deep venous thrombosis in medial-surgical critically ill patients: Prevalence, incidence, and risk factors. Crit Care Med. 2005;33:1565–1571.
6.
HirschDRIngenitoEPGoldhaberSZ. Prevalence of deep venous thrombosis among patients in medical intensive care. JAMA. 1995;274:335–337.
7.
Product Information: Arixtra®, fondaparinux sodium injection. GlaxoSmithKline, Research Triangle Park, NC, 2010.
8.
CadeJF. High risk of the critically ill for venous thromboembolism. Crit Care Med. 1982;10:448–450.
9.
FraisseFHolzapfelLCoulaudJ. Nadroparin in the prevention of deep vein thrombosis in acute decompensated COPD. Am J Respir Crit Care Med. 2000;161:1109–1114.
10.
CookDJRockerGMeadeM. Prophylaxis of thromboembolism in critical care (PROTECT) trial: A pilot study. J Crit Care. 2005;20:364–372.
11.
KingCSHolleyABJacksonJL. Twice vs three times daily heparin dosing for thromboembolism prophylaxis in the general medical population: A metaanalysis. Chest. 2007;131:507–516.
12.
Product Information: Fragmin®, dalteparin sodium injection. Pfizer, Inc, New York, NY, 2007.
RobinsonSZincukAStrømT. Enoxaparin, effective dosage for intensive care patients: Double-blinded, randomised clinical trial. Crit Care. 2010;14:R41.
15.
HaasCENelsonJLRaghavendranK. Pharmacokinetics and pharmacodynamics of enoxaparin in multiple trauma patients. J Trauma. 2005;59:1336–1344.
16.
LimpusAChaboyerWMcDonaldE. Mechanical thromboprophylaxis in critically ill patients: A systematic review and meta-analysis. Am J Crit Care. 2006;15:402–412.
17.
. The perioperative management of antithrombotic therapy. Chest. 2008;133:299S–339S.
18.
CookDJCrowtherMA. Thromboprophylaxis in the intensive care unit: Focus on medical-surgical patients. Crit Care Med. 2010;38[supp.]:S76–S82.
19.
RabbatCGCookDJCrowtherMA. Dalteparin thromboprophylaxis for critically ill medical-surgical patients with renal insufficiency. J Crit Care. 2005;20:357–363.
20.
CookDDouketisJMeadeM. Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin thromboprophylaxis: Prevalence, incidence, and risk factors. Crit Care. 2008;12:R32.
21.
KucherNLeizoroviczAVaitkusPT. Efficacy and safety of fixed low-dose dalteparin in preventing venous thromboembolism among obese or elderly hospitalized patients. Arch Intern Med. 2005;165:341–5.
22.
CookDJDouketisJArnoldD. Bleeding and venous thromboembolism in the critically ill with emphasis on patients with renal insufficiency. Curr Opin Pulm Med. 2009;15:455–462.
23.
DouketisJCookDMeadeM. Prophylaxis against deep vein thrombosis in critically ill patients with severe renal insufficiency with the low-molecular-weight heparin dalteparin. Arch Intern Med. 2008;168:1805–1812.
24.
RobertsonMSCadeJFClanceyRL. Helicobacter pylori infection in intensive care: Increased prevalence and a new nosocomial infection. Crit Care Med. 1999;27:1276–80.
CookDJFullerHDGuyattGH. Risk factors for gastrointestinal bleeding in critically ill patients. N Engl J Med. 1994;330:377–381.
27.
Ben-MenachemTFogelRPatelRV. Prophylaxis for stress-related gastric hemorrhage in the medical intensive care unit. Ann Intern Med. 1994;121:568–575.
28.
CookDJGriffithLEWalterSD. The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients. Crit Care. 2001;5:368–375.
29.
TsiotosGGMullanyCJZietlowS. Abdominal complications following cardiac surgery. Am J Surg. 1994;167:553–557.
30.
ChoCHKooMWGargGP. Stress-induced gastric ulceration: Its aetiology and clinical implications. Scand J Gastroenterol. 1992;27:257–262.
31.
BowenJCFlemingWHThompsonJC. Increased gastrin release following penetration central nervous system injury. Surgery. 1974;75:720–724.
32.
WattsCCClarkK. Gastric acidity in the comatose patient. J Neurosurg. 1969;30:107–109.
33.
O’NeillJA. The influence of thermal burns on gastric acid secretion. Surgery. 1970;67:267–271.
34.
GudemanSKWheelerCBMillerJD. Gastric secretory and mucosal injury response to severe head trauma. Neurosurgery. 1983;12:175–179.
35.
MutluGMMutluEAFactorP. GI complications in patients receiving mechanical ventilation. Chest. 2001;119:1222–1241.
36.
MaynardNBihariDJBealeR. Assessment of splanchnic oxygenation by gastric tonometry in patients with acute circulatory failure. JAMA. 1993;270:1203–1210.
37.
PimentelMRobertsDEBernsteinCN. Clinically significant gastrointestinal bleeding in critically ill patients in an era of prophylaxis. Am J Gastroenterol. 2000;95:2801–2806.
38.
LevinNGThornSELindbergG. Dopamine reduces gastric tone in a dose-related manner. Acta Anaesthesiol Scand. 1999;43:722–725.
39.
HalmUHalmFTheinD. Helicobacter pylori infection: A risk factor for upper gastrointestinal bleeding after cardiac surgery?Crit Care Med. 2000;28:110–113.
40.
van der VoortPHvan der HulstRWZandstraDF. Prevalence of Helicobacter pylori infection in stress-induced gastric mucosal injury. Intensive Care Med. 2001;27:68–73.
41.
ScusterDPRowleyHFeinsteinS. Prospective evaluation of the risk of upper gastrointestinal bleeding after admission to a medical intensive care unit. Am J Med. 1984;76:623–630.
42.
EstruchRPedrolECastellesA. Prophylaxis of gastrointestinal tract bleeding with magaldrate in patients admitted to a general hospital ward. Scand J Gastroenterol. 1991;26:819–826.
43.
ShumanRBSchusterDPZuckermanGR. Prophylactic therapy for stress ulcer bleeding: A reappraisal. Ann Intern Med. 1987;106:562–567.
44.
MartinLFBoothFVReinesD. Stress ulcers and organ failure in intubated patients in surgical intensive care units. Ann Surg. 1992;215:332–337.
45.
LayonAJFloreteODayAL. The effect of duodenojejunal alimentation on gastric pH and hormones in intensive care unit patients. Chest. 1991;99:695–702.
46.
PingletonSKHadzimaSK. Enteral alimentation and gastrointestinal bleeding in mechanically ventilated patients. Crit Care Med. 1983;11:13–16.
47.
Ben-MenachemTMcCarthyBDFogelR. Prophylaxis for stress-related gastrointestinal hemorrhage: A cost effectiveness analysis. Crit Care Med. 1996;24:338–345.
48.
Ruiz-SantanaSOrtizEGonzalezB. Stress-induced gastroduodenal lesions and total parenteral nutrition in critically ill patients: Frequency, complications, and the value of prophylactic treatment: A prospective, randomized study. Crit Care Med. 1991;19:887–891.
49.
McCarthyDM. Sucralfate. N Engl J Med. 1991;325:1017–1025.
50.
TrybaMCookD. Current guidelines on stress ulcer prophylaxis. Drugs. 1997;54:581–596.
51.
BontenMJGaillardCAvan der GeestS. The role of intragastric acidity and stress ulcus prophylaxis on colonization and infection in mechanically ventilated patients. A stratified, randomized, double-blind study of sucralfate versus antacids. Am J Resp Crit Care Med. 1995;152:1825–1834.
52.
Prod’homGLeuenbergerPKoerferJ. Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer. A randomized, controlled trial. Ann Internal Med. 1994;120:653–662.
53.
ThomasonMHPayseurESHakenewerthAM. Nosocomial pneumonia in ventilated trauma patients during stress ulcer prophylaxis with sucralfate, antacid, and ranitidine. J Trauma. 1996;41:503–508.
54.
CookDGuyattGMarshallJ. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. N Engl J Med. 1998;338:791–797.
55.
HastingsPRSkillmanJJBushnellLS. Antacid titration in the prevention of acute gastrointestinal bleeding: A controlled, randomized trial in 100 critically ill patients. N Engl J Med. 1978;298:1041–1045.
56.
FeldmanMBurtonME. Histamine2-receptor antagonists. Standard therapy for acid-peptic diseases. N Engl J Med. 1990;323:1672–1680.
57.
BaghaieAAMojtahedzadehMLevineRL. Comparison of the effects of intermittent administration and continuous infusion of famotidine on gastric pH in critically ill patients: Results of a prospective randomized, crossover study. Crit Care Med. 1995;23:687–691.
58.
ErstadBLBarlettaJFJacobiJ. Survey of stress ulcer prophylaxis. Crit Care. 1999;3:145–149.
59.
NetzerPGaiaCSandozM. Effect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 hours. Am J Gastroenterol. 1999;94:351–357.
60.
MerkiHSWilder-SmithCH. Do continuous infusions of omeprazole and ranitidine retain their effect with prolonged dosing?Gastroenterology. 1994;106:60–64.
61.
CookDJWittLACookRJ. Stress ulcer prophylaxis in the critically ill: A meta-analysis. Am J Med. 1991;91:519–527.
62.
LaskyMRMetzlerMHPhillipsJO. A prospective study of omeprazole suspension to prevent clinically significant gastrointestinal bleeding from stress ulcers in mechanically ventilated trauma patients. J Trauma. 1998;44:527–533.
63.
PhillipsMetzlerMHPalmieriTL. A prospective study of simplified omeprazole suspension for the prophylaxis of stress-related mucosal damage. Crit Care Med. 1996;24:1793–1800.
64.
LevyMGSeeligCBRobinsonNJ. Comparison of omeprazole and ranitidine for stress ulcer prophylaxis. Dig Dis Sci. 1997;42:1255–1259.
65.
ConradSAGabrielleAMargolisB. Randomized, double-blind comparison of immediate-release omeprazole suspension versus intravenous cimetidine for the prevention of gastrointestinal bleeding in critically ill patients. Crit Care Med. 2005;33:760–765.
66.
MooreJGCoburnJWSandersMC. Effects of sucralfate and ranitidine on aluminum concentrations in elderly volunteers. Pharmacotherapy. 1995;15:742–746.
67.
BurgessEMuruveDAudetteR. Aluminum absorption and excretion following sucralfate therapy in chronic renal insufficiency. Am J Med. 1992;92:471–475.
68.
AndersonWWeatherstoneG. Esophageal medication bezoar in a patient receiving enteral feedings and sucralfate. Am J Gastroenterol. 1989;84:205–206.
69.
GuayDR. The role of fluoroquinolones. Pharmacotherapy. 1992;12:71S–85S.
70.
MarcuaradSPPerkinsAM. Clogging of feeding tubes. J Parenter Enteral Nutr. 1988;12:403–405.
71.
AymardJPAymardBNetterP. Haematological adverse effects of histamine H2-receptor antagonists. Med Toxicol. 1988;3:430–438.
72.
WadeEERebuckJAHealeyME. H(2) antagonist-induced thrombocytopenia: Is this a real phenomenon?Intensive Care Med. 2002;28:459–465.
73.
CawleyMJWittbrodtETBoyceEG. Potential risk factors associated with thrombocytopenia in a surgical intensive care unit. Pharmacotherapy. 1999;19:108–113.
74.
WelageLSBarardiRR. Drug interactions with antiulcer agents: Considerations in the treatment of acid-peptic disease. J Pharmacy Practice. 1994;7:177–195.
75.
PuffMRCareyWD. The effect of cimetidine on cyclosporine A levels in liver transplant recipients: A preliminary report. Am J Gastroenterol. 1992;87:287–291.
LastEJSheehanAH. Review of recent evidence: Potential interaction between clopidogrel and proton pump inhibitors. Am J Health-Syst Pharm. 2009;55:2117–2122.
78.
MessoriATrippoliSVaianiM. Bleeding and pneumonia in intensive care patients given ranitidine and sucralfate for prevention of stress ulcer: Meta-analysis of randomised controlled trials. BMJ. 2000;321:1103–1106.
79.
TorresAEl-EbiaryNSolerC. Stomach as a source of colonization of the respiratory tract during mechanical ventilation: Association with ventilator-associated pneumonia. Eur Respir J. 1996;9:1729–1735.
80.
IbrahimEHTracyLHillC. The occurrence of ventilator-associated pneumonia in a community hospital. Chest. 2001;120:555–561.
81.
MianoTAReichertMGHouleTT. Nosocomial pneumonia risk and stress ulcer prophylaxis: A comparison of pantoprazole vs. ranitidine in cardiothoracic surgery patients. Chest. 2009;136:440–447.
82.
BontenMJGuillardCAde LeeuwPW. Role of colonization of the upper intestinal tract in the pathogenesis of ventilator-associated pneumonia. Clin Infect Dis. 1997;24:309–319.
83.
DePriestJL. Stress ulcer prophylaxis: Do critically ill patients need it?Postgrad Med. 1995;98:159–161.
84.
MartinLFBoothFVReinesHD. Stress ulcers and organ failure in intubated patients in surgical intensive care units. Ann Surg. 1992;215:332–337.
85.
LamNPLePDCrawfordSY. National Survey of stress ulcer prophylaxis. Crit Care Med. 1999;27:98–103.
86.
BarlettaJFErstadBLFortuneJB. Stress ulcer prophylaxis in trauma patients. Crit Care. 2002;6:526–530.
87.
NavabFSteingrubJ. Stress ulcer: Is routine prophylaxis necessary?Am J Gastroenterol. 1995;90:708–712.
88.
DevlinJWBen-MenachemTUlepSK. Stress ulcer prophylaxis in medical ICU patients: Annual utilization in relation to the incidence of endoscopy-proven stress ulceration. Ann Pharmacother. 1998;32:869–874.
89.
FaisyCGuerotEDiehlJL. Clinically significant gastrointestinal bleeding in critically ill patients with and without stress ulcer prophylaxis. Intensive Care Med. 2003;29:1306–1313.
